Mizukami K
Department of Medicine, Kidney Center, Tokyo Women's Medical College, Japan.
Nihon Jinzo Gakkai Shi. 1990 Jan;32(1):1-11.
Intravenous sodium bicarbonate (NaHCO3) infusion test was performed in 26 patients with chronic glomerulonephritis (CGN) and 16 with distal renal tubular acidosis (dRTA) in order to evaluate urinary acidifying capacity in chronic renal diseases. Comparative studies with glomerular filtration were planned, so that the patients with CGN were divided by creatinine clearance (Ccr) into 3 groups (G-I greater than or equal to 70, 30 less than or equal to G-II less than 70, G-III less than 30 ml/min). Proximal tubular bicarbonate (HCO3) reabsorption rate increased in CGN as Ccr decreased. Urine to blood carbon dioxide tension gradient (U-B PCO2) was above 30 mmHg in controls and below 20 mmHg in dRTA. In patients with CGN, urine HCO3 concentration (UHCO3) did not increase during NaHCO3 loading as Ccr decreased. However, U-B PCO2 rose above 20 mmHg, when UHCO3 was above 50 ml/min. Fishberg concentrating test was also performed in 15 patients with CGN and 6 with dRTA so that the relationship between urinary concentrating ability and urine acidification might be evaluated. While both functions were decreased in dRTA, U-B PCO2 in alkaline urine remained above 20 mmHg in CGN associated with moderate renal dysfunction (Ccr greater than or equal to 30 ml/min) despite decreased maximal urine osmolality. Intravenous furosemide (FM) injection test was carried out in 8 patients with chronic renal failure (CRF) and 3 with dRTA. Minimal urine pH fell below 5.5 and net acid excretion (NAE) increased in controls, whereas these responses were not seen in dRTA. In CRF, urine pH generally decreased below 5.5 and those who had a similar response to FM as dRTA, seemed to have more severe disturbance of the distal acidification. In conclusion, U-B PCO2 in alkaline urine and lowered urine pH in FM loading appeared to be a useful index of distal tubular acid excretion in patients with renal dysfunction. In CGN with moderate renal dysfunction (Ccr greater than or equal to 30 ml/min), urinary acidifying capacity remained normal in comparison with decreased urine concentrating ability.
对26例慢性肾小球肾炎(CGN)患者和16例远端肾小管酸中毒(dRTA)患者进行静脉输注碳酸氢钠(NaHCO₃)试验,以评估慢性肾脏疾病的尿酸化能力。计划进行与肾小球滤过的对比研究,因此将CGN患者按肌酐清除率(Ccr)分为3组(G-I大于或等于70,30小于或等于G-II小于70,G-III小于30 ml/min)。随着Ccr降低,CGN患者近端肾小管碳酸氢盐(HCO₃)重吸收率增加。对照组尿-血二氧化碳分压梯度(U-B PCO₂)高于30 mmHg,而dRTA患者低于20 mmHg。在CGN患者中,随着Ccr降低,NaHCO₃负荷期间尿HCO₃浓度(UHCO₃)未增加。然而,当UHCO₃高于50 ml/min时,U-B PCO₂升至20 mmHg以上。还对15例CGN患者和6例dRTA患者进行了Fishberg浓缩试验,以评估尿浓缩能力与尿酸化之间的关系。虽然dRTA患者这两种功能均降低,但在伴有中度肾功能不全(Ccr大于或等于30 ml/min)的CGN患者中,尽管最大尿渗透压降低,但碱性尿中的U-B PCO₂仍高于20 mmHg。对8例慢性肾衰竭(CRF)患者和3例dRTA患者进行了静脉注射呋塞米(FM)试验。对照组最小尿pH降至5.5以下,净酸排泄(NAE)增加,而dRTA患者未出现这些反应。在CRF患者中,尿pH通常降至5.5以下,那些对FM有与dRTA相似反应的患者,似乎远端酸化障碍更严重。总之,碱性尿中的U-B PCO₂和FM负荷时尿pH降低似乎是肾功能不全患者远端肾小管酸排泄的有用指标。在伴有中度肾功能不全(Ccr大于或等于30 ml/min)的CGN患者中,与降低的尿浓缩能力相比,尿酸化能力保持正常。